Late sequela after treatment of childhood low-grade gliomas: a retrospective analysis of 69 long-term survivors treated between 1983 and 2003

  • Martin BeneschEmail author
  • Herwig Lackner
  • Petra Sovinz
  • Elisabeth Suppan
  • Wolfgang Schwinger
  • Hans-Georg Eder
  • Hans Jürgen Dornbusch
  • Andrea Moser
  • Karin Triebl-Roth
  • Christian Urban
Clinical–patient studies


The aim of the present study was to evaluate the spectrum of late effects in a large cohort of pediatric patients with low-grade gliomas (WHO grade I and II) during an observation period of 20 years. Eighty-seven patients with low-grade gliomas grouped according to tumor location (cerebellum: n=28; cerebral hemispheres: n=21; central midline: n=15; brainstem: n=12; tectum: n=5; other locations: n=6) were evaluated for tumor- and/or treatment-related late effects by analysis of medical and computer records, and personal interviews. Seventy patients underwent neurosurgery, 29 patients received additional radiotherapy and 20 additional chemotherapy. Median follow-up of survivors is 96 months with an overall survival of 79% (cerebellum: 89%; cerebral hemispheres: 95%; central midline: 80%; brainstem: 25%; tectum: 100%; other locations: 66%). Chronic medical problems (mild ataxia to multiple severe neuroendocrine deficits) are observed in 100% of patients with brainstem/central midline tumors and in 40–50% of patients with low-grade gliomas of other locations. Endocrine deficiencies were observed in 15/17 (88%) of long-term survivors who received radiotherapy. In contrast, none of the patients who underwent surgery only had endocrine deficiencies. Seven long-term survivors (10.1%) are severely disabled with permanent need of medical help. Tumor- and treatment-related late effects are common in patients with low-grade gliomas with the most severe occurring in patients with brainstem or central midline tumors. As long-term survival is excellent in patients with low-grade gliomas except for tumors located in the brainstem, future treatment studies should focus on avoiding long-term late effects.


children late effects low-grade gliomas outcome treatment 


  1. 1.
    Giannini C, Scheithauer BW, Classification and grading of low-grade astrocytic tumors in children Brain Pathol 7: 785–798, 1997PubMedCrossRefGoogle Scholar
  2. 2.
    Pollack IF, Brain tumors in children New Engl J Med 331: 1500–1507, 1994PubMedCrossRefGoogle Scholar
  3. 3.
    Gajjar A, Sanford RA, Heideman R, Jenkins JJ, Walter A, Li Y, Langston JW, Muhlbauer M, Boyett JM, Kun LE, Low-grade astrocytoma: a decade of experience at St. Jude Children`s Research Hospital J Clin Oncol 15: 2792–2799, 1997PubMedGoogle Scholar
  4. 4.
    Pollack IF, Claassen D, al-Shboul Q, Janosky JE, Deutsch M, Low-grade gliomas of the cerebral hemispheres in children. An analysis of 71 cases J Neurosurg 82: 536–547, 1995PubMedGoogle Scholar
  5. 5.
    Pencalet P, Maixner W, Sainte-Rose C, Lellouch-Tubiana A, Cinalli G, Zerah M, Pierre-Kahn A, Hoppe-Hirsch E, Bourgeois M, Renier D, Benign cerebellar astrocytomas in children J Neurosurg 90: 265–273, 1999PubMedCrossRefGoogle Scholar
  6. 6.
    Flickinger JC, Torres C, Deutsch M, Management of low-grade gliomas of the optic nerve and chiasm Cancer 61: 635–642, 1988PubMedCrossRefGoogle Scholar
  7. 7.
    Kortmann RD, Timmermann B, Taylor RE, Scarzello G, Plasswilm L, Paulsen F, Jeremic B, Gnekow AK, Dieckmann K, Kay S, Bamberg M, Current and future strategies in radiotherapy of childhood low-grade glioma of the brain Strahlenther Onkol 179: 509–520, 2003PubMedCrossRefGoogle Scholar
  8. 8.
    Reddy AT, Packer RJ, Chemotherapy for low-grade gliomas Child's Nerv Syst 15: 506–513, 1999CrossRefGoogle Scholar
  9. 9.
    Watson GA, Kadota RP, Wisoff JH, Multidisciplinary management of pediatric low-grade gliomas Semin Radiat Oncol 11: 152–162, 2001PubMedCrossRefGoogle Scholar
  10. 10.
    Gnekow AK, Kortmann RD, Pietsch T, Emser A, Low grade chiasmatic–hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy. Report from the multicenter treatment study for children and adolescents with a low grade glioma-HIT-LGG 1996. Society of the Pediatric Oncology and Hematology (GPOH) Klin Pädiatr 216: 331–342, 2004PubMedCrossRefGoogle Scholar
  11. 11.
    Silva MM, Goldman S, Keating G, Marymont MA, Kalapurakal J, Tomita T, Optic pathway hypothalamic gliomas in children under three years of agethe role of chemotherapy. Pediatr Neurosurg 33: 151–158, 2000PubMedCrossRefGoogle Scholar
  12. 12.
    Shaw EG, Wisoff JH, Prospective clinical trials of intracranial low-grade glioma in adults and children Neurooncology 5: 153–160, 2003Google Scholar
  13. 13.
    Bowers DC, Georgiades C, Aronson LJ, Carson BS, Weingart JD, Wharam MD, Melhem ER, Burger PC, Cohen KJ, Tectal gliomas: natural history of an indolent lesion in pediatric patients Pediatr Neurosurg 32: 24–29, 2000PubMedCrossRefGoogle Scholar
  14. 14.
    Packer RJ, Boyett JM, Zimmerman RA, Leland Albright A, Kaplan AM, Rorke LB, Selch MT, Cherlow JM, Finlay JL, Wara WM, Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy Cancer 74: 1827–1834, 1994PubMedCrossRefGoogle Scholar
  15. 15.
    Freeman CR, Suissa S, Brain stem tumors in children: results of a survey of 62 patients treated with radiotherapy Int J Radiat Oncol Biol Phys 12: 1823–1828, 1986PubMedGoogle Scholar
  16. 16.
    Benesch M, Lackner H, Moser A, Kerbl R, Schwinger W, Oberbauer R, Eder HG, Mayer R, Wiegele K, Urban C, Outcome and long-term side effects after synchronous radiochemotherapy for childhood brain stem gliomas Pediatr Neurosurg 35: 173–180, 2001PubMedCrossRefGoogle Scholar
  17. 17.
    Kleihues P, Burger PC, Scheithauer BW, Histological Typing of Tumours of the Central Nervous System 2nd ed. Springer-Verlag Berlin 1993Google Scholar
  18. 18.
    Gnekow A, Recommendations of the brain tumor subcommittee for the reporting of trials Med Pediatr Oncol 24: 104–108, 1995PubMedCrossRefGoogle Scholar
  19. 19.
    Savage DC, Swift PG, Johnston PG, Goldie DJ, Murphy D, Combined test of anterior pituitary function in children Arch Dis Child 53: 301–304, 1978PubMedCrossRefGoogle Scholar
  20. 20.
    Stevens MC, Mahler H, Parkes S, The health status of adult survivors of cancer in childhood Eur J Cancer 34: 694–698, 1998PubMedCrossRefGoogle Scholar
  21. 21.
    Lackner H, Benesch M, Schagerl S, Kerbl R, Schwinger W, Urban C, Prospective evaluation of late effects after childhood cancer therapy with a follow-up over 9 years Eur J Pediatr 159: 750–758, 2000 PubMedCrossRefGoogle Scholar
  22. 22.
    Allen JC, The effects of cancer therapy on the nervous system J Pediatr 93: 903–909, 1978PubMedCrossRefGoogle Scholar
  23. 23.
    Danoff BF, Cowchock FS, Marquette C, Mulgrew L, Kramer S, Assessment of the long-term effects of primary radiation therapy for brain tumors in children Cancer 49: 1580–1586, 1982PubMedCrossRefGoogle Scholar
  24. 24.
    Li FP, Winston KR, Gimbrere K, Follow-up of children with brain tumors Cancer 54: 135–138, 1984PubMedCrossRefGoogle Scholar
  25. 25.
    Mostow EN, Byrne J, Connelly RR, Mulvihill JJ, Quality of life in long-term survivors of CNS tumors of childhood and adolescence J Clin Oncol 9: 592–599, 1991PubMedGoogle Scholar
  26. 26.
    Packer RJ, Gurney JG, Punyko JA, Donaldson SS, Inskip PD, Stovall M, Yasui Y, Mertens AC, Sklar CA, Nicholson HS, Zeltzer LK, Neglia JP, Robison LL, Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: Childhood Cancer Survivor Study J Clin Oncol 21: 3255–3261, 2003PubMedCrossRefGoogle Scholar
  27. 27.
    Brauner R, Malandry F, Rappaport R, Zucker JM, Kalifa C, Pierre-Kahn A, Bataini P, Dufier JL, Growth and endocrine disorders in optic glioma Eur J Pediatr 149: 825–828, 1990PubMedCrossRefGoogle Scholar
  28. 28.
    Collet-Solberg PF, Sernyak H, Satin-Smith M, Katz LL, Sutton L, Molloy P, Moshang Jr T, Endocrine outcome in long-term survivors of low-grade hypothalamic/chiasmatic gliomas Clin Endocrinol 47: 79–85, 1997CrossRefGoogle Scholar
  29. 29.
    Cappelli C, Grill J, Raquin M, Pierre-Kahn A, Lellouch-Tubiana A, Terrier-Lacombe MJ, Habrand JL, Couanet D, Brauner R, Rodriguez D, Hartmann O, Kalifa C, Long term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era Arch Dis Child 79: 334–338, 1998PubMedGoogle Scholar
  30. 30.
    Grabenbauer GG, Schuchardt U, Buchfelder M, Rödel CM, Gusek G, Marx M, Doerr HG, Fahlbusch R, Huk WJ, Wenzel D, Sauer R, Radiation therapy of optico-hypothalamic gliomas (OHG) – radiographic response, vision and late toxicity Radiother Oncol 54: 239–245, 2000 PubMedCrossRefGoogle Scholar
  31. 31.
    Chadderton RD, West CG, Schulz S, Quirke DC, Gattamaneni R, Taylor R, Radiotherapy in the treatment of low-grade astrocytomas. II. The physical and cognitive sequelae Child's Nerv Syst 11: 443–448, 1995CrossRefGoogle Scholar
  32. 32.
    Taphoorn MJ, Schiphorst AK, Snoeck FJ, Lindeboom J, Wolbers JG, Karim AB, Huijgens PC, Heimans JJ, Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy Ann Neurol 36: 48–54, 1994PubMedCrossRefGoogle Scholar
  33. 33.
    Fouladi M, Wallace D, Langston JW, Mulhern R, Rose SR, Gajjar A, Sanford RA, Merchant TE, Jenkins JJ, Kun LE, Heideman RL, Survival and functional outcome of children with hypothalamic/chiasmatic tumors Cancer 97: 1084–1092, 2003PubMedCrossRefGoogle Scholar
  34. 34.
    Hildebrand J, Lecaille C, Perennes J, Delattre JY, Epileptic seizures during follow-up of patients treated for primary brain tumors Neurology 65: 212–215, 2005PubMedCrossRefGoogle Scholar
  35. 35.
    Beebe DW, Ris MD, Armstrong FD, Fontanesi J, Mulhern R, Holmes E, Wisoff JH, Cognitive and adaptive outcomes in low-grade pediatric cerebellar astrocytomas: evidence of diminished cognitive and adaptive functioning in national collaborative research studies (CCG 9891/POG 9130) J Clin Oncol 23: 5198–5204, 2005PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Martin Benesch
    • 1
    • 4
    Email author
  • Herwig Lackner
    • 1
  • Petra Sovinz
    • 1
  • Elisabeth Suppan
    • 2
  • Wolfgang Schwinger
    • 1
  • Hans-Georg Eder
    • 3
  • Hans Jürgen Dornbusch
    • 1
  • Andrea Moser
    • 1
  • Karin Triebl-Roth
    • 1
  • Christian Urban
    • 1
  1. 1.Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent MedicineMedical University of GrazGrazAustria
  2. 2.Division of General Pediatrics, Department of Pediatrics and Adolescent MedicineMedical University of GrazGrazAustria
  3. 3.Department of NeurosurgeryMedical University of Graz GrazAustria
  4. 4.Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent MedicineMedical University of GrazGrazAustria

Personalised recommendations